Is Moderna Really the Leader in the COVID-19 Vaccine Race?
When Dr. Anthony Fauci speaks, people listen. The director of the National Institute of Allergy and Infectious Diseases (NIAID) quickly became a top spokesperson for the U.S. effort to fight the COVID pandemic earlier this year.
There's one company that Fauci has singled out among the several that are developing COVID-19 vaccine candidates. That drugmaker is Moderna (NASDAQ: MRNA).
And when The New York Times reported a few days ago that the Trump administration has picked five COVID-19 vaccines to receive substantial financial support of the U.S. government, there was one company mentioned first. You guessed it... Moderna.
Source Fool.com
